
Yoichiro Matsumoto
Professor Emeritus, The University of Tokyo; Chair, ME-BYO Summit Kanagawa Executive Committee
Main Event
Kanagawa Prefecture has held the ME-BYO Summit to promote the ME-BYO concept and the importance of improving ME-BYO, expand the market for Kanagawa's ME-BYO industries, and build a sustainable society where people enjoy long, healthy lives. We are pleased to announce the international symposium, ME-BYO Summit Kanagawa 2026 Autumn: From Hakone to the World.
Wednesday, November 4, 2026, 13:00–17:40
Thursday, November 5, 2026, 09:20–16:50
Yumoto Fujiya Hotel
(256-1 Yumoto, Hakone-machi, Ashigarashimo-gun, Kanagawa, Japan)
Invited guests, event stakeholders and members of the press may attend in person.
Recorded videos will be made available to the public after the event.
The Convergence of ME-BYO and Cutting-Edge Science & Technology — Advancing ME-BYO Innovation through Industry–Academia–Government–Community Collaboration —
From the ME-BYO Index and practical ME-BYO improvement to diverse ME-BYO industry initiatives and innovation through cutting-edge science and technology,
municipalities, businesses and academic institutions working on real-world challenges will join distinguished researchers from Japan and overseas to discuss the way forward.
Program
This session will explore practical initiatives for ME-BYO management in everyday settings and discuss perspectives, challenges, and future prospects for building age-friendly communities that support people of all generations.
This session will discuss advances in visualizing and managing ME-BYO through cutting-edge technologies, as well as challenges and future prospects for practical implementation.
This session will examine the potential of health innovations as emerging approaches to ME-BYO management and healthcare, drawing on advances in genomics, gut microbiome research, and health data utilization.
Program
This lecture will examine the prospects for advanced medical and ME-BYO industries and collaborative innovation under the Healthcare New Frontier initiative, from the perspective of public interest capitalism.
This session will highlight initiatives to foster emerging industries at Kanagawa’s innovation hubs, including Tonomachi and Shin-Shonan, and discuss strategies for their further development, encompassing demonstration, evaluation, and social implementation.
This session will discuss initiatives to visualize and manage ME-BYO across diverse community settings, with a focus on the multifaceted value creation and future potential of ME-BYO industries in supporting a society of increasing longevity.
This session will examine patient-centered approaches to ME-BYO management that promote physical, mental, and cognitive well-being, focusing on their medical significance and the integration of ME-BYO initiatives with healthcare.
This session will explore the future development of ME-BYO policies toward a society where every life shines (Vibrant INOCHI), highlighting initiatives in arts and culture and community engagement.
This session will discuss the development of a “ME-BYO Social System” aimed at advancing ME-BYO management and addressing the challenges of a super-aged society, drawing on the expansion of ME-BYO industries and growing data-driven evidence.
This session will review the discussions held throughout the ME-BYO Summit, summarize key outcomes, and present a forward-looking vision for future development.
Speakers

Professor Emeritus, The University of Tokyo; Chair, ME-BYO Summit Kanagawa Executive Committee

Speaker of the Kanagawa Prefectural Assembly

Governor of Kanagawa Prefecture; Honorary Chair, ME-BYO Summit Kanagawa Executive Committee

President, Yokohama National University

Mayor of Oi Town

Technical Lead, Healthy Ageing, Division of Data, Strategy and Innovation, WHO Regional Office for the Western Pacific

Mayor of Isehara City

Business Strategy Advisor, MIKAWAYA21 Inc.

Board Member and Vice President, Kanagawa University of Human Services; Dean, Graduate School of Health Innovation; Advisor to Kanagawa Prefecture

President and CEO, CYBERDYNE Inc.; Professor, University of Tsukuba; Program Director of SIP, Cabinet Office

Professor, Department of System Design Engineering, Faculty of Science and Technology, Keio University

Specially-Appointed Vice President, Professor, Center for Promotion of Research and Industry-Academic Collaboration, Yokohama City University

Professor, Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine

Director and Executive Managing Director, Central Institute for Experimental Medicine and Life Science; Professor Emeritus, Keio University

Professor, School of Life Science and Technology, Institute of Science Tokyo; Joint Representative Director and CSO, Logomix Inc.

Professor, Keio University School of Medicine; Director, Center for Cancer Genomics

Project Professor, Institute for Advanced Biosciences, Keio University; President and CEO, Metagen Inc.

The Isabel Chan Professor in Medical Sciences, Executive Director, Centre for Population Health, National University of Singapore; Executive Director, The Yong Pung How and Yong Wei-Woo Centre; Senior Advisor, National University Health System

Chairman, Alliance Forum Foundation; Honorary Professor, Li Ka Shing Faculty of Medicine, The University of Hong Kong

Associate Director General (ME-BYO and Special Missions), Policy Bureau, Kanagawa Prefectural Government

Professor and Chair, Department of Orthopaedic Surgery, Keio University School of Medicine

Professor, School of Health Innovation / Director, Center for Innovation Policy, Kanagawa University of Human Services

CEO and Chairman of the Board, Central Institute for Experimental Medicine and Life Science (CIEM); President of the KING SKYFRONT NetWork Council; Visiting Professor, Fujita Health University

Special Honorary Professor, Graduate School of Medicine, Tohoku University; Special Advisor to the Director-General, Tohoku Medical Megabank Organization

Professor, Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine; Director, SDLDDRS

President and CEO, IDP Publishing Inc.

General Manager, Future Business Development Department, SOYOKAZE Co., Ltd.; General Manager, Magellan Shonan Sajima

Chairman, Jikeikai Medical Corporation; Chairman, Keijinkai Social Welfare Corporation; President, Jogakura Tourism Co.

Professor, Graduate School of Health Innovation, Kanagawa University of Human Services

President, Yokohama City University

Chairman, Minatomirai Medical Corporation; Senior Advisor (Convenor), Sleep Environment Research Association

Vice Chairman of the Board, General Incorporated Association Tokushukai and Medical Corporation Tokushukai; President and CEO, Shonan Kamakura General Hospital

Professor, Faculty of Engineering, Yokohama National University

Professor, Graduate School of Public Policy, The University of Tokyo; Vice Representative Director, Society of Well-being; Specially Appointed Professor, Keio University

President of Public University Corporation, Kanagawa University of Human Services

Professor Emeritus, Faculty of Economics, Keio University

Vice Governor of Kanagawa Prefecture; Vice Chair, ME-BYO Summit Kanagawa Executive Committee

Professor, Psychiatry and Behavioral Sciences, Stanford University School of Medicine

Mayor of Hakone Town; Vice Chair, ME-BYO Summit Kanagawa Executive Committee
News
About ME-BYO
Our physical and mental condition continuously shifts along a spectrum between health and illness. ME-BYO is a term that describes this state. Through ME-BYO management, the summit aims to help build a sustainable society where people enjoy long, healthy lives.
The ME-BYO Index uses numerical and other measures to show your current ME-BYO status across four areas: lifestyle, cognitive function, physical function, and mental health and stress. You can take the assessment in your browser.
Measure your ME-BYO Index (opens in a new window) Assess your cognitive function (opens in a new window)Next Event
The autumn event will take place in Hakone as the culmination of a five-event series spanning 2025–2026. Details will be announced on this website when confirmed.
The five-event series at a glanceContact
FUNmedication Co., Ltd.
3-4-204 Tsurumaki, Tama, Tokyo 206-0034, Japan
Email:kanagawa@funmedi.co.jp
Profile
Affiliation details will be provided later.